Our results show that in pancreatic cancer, NGAL is predominantly expressed in the early dysplastic lesions as well as in the well-differentiated carcinomas (preserve ductal architecture); with almost no expression in the poorly differentiated tumours (have a predominantly mesenchymal appearance). This evidence concerns the gene LCN2 and pancreatic neoplasm.